Sreerama L, Sladek N E
Department of Pharmacology, University of Minnesota Medical School, Minneapolis 55455.
Cancer Res. 1994 Apr 15;54(8):2176-85.
The class-3 aldehyde dehydrogenase that is overexpressed (> 100-fold) in human breast adenocarcinoma MCF-7/0 cells made resistant (> 30-fold as judged by LC90s) to oxazaphosphorines, such as mafosfamide, by growing them in the presence of polycyclic aromatic hydrocarbons, e.g., methylcholanthrene (3 microM for 5 days), was isolated and characterized. Its physical and catalytic properties were identical to those of the prototypical human stomach mucosa cytosolic class-3 aldehyde dehydrogenase, type-1 ALDH-3, except that it catalyzed, though not very rapidly, the oxidation of aldophosphamide, whereas the stomach mucosa enzyme essentially did not; hence, it was judged to be a slight variant of the prototypical enzyme. Carcinogens that are not ligands for the Ah receptor, barbiturates known to induce hepatic cytochrome P450s, steroid hormones, an antiestrogen, and oxazaphosphorines did not induce the enzyme or the largely oxazaphosphorine-specific acquired resistance. Whereas methylcholanthrene induced (a) resistance to mafosfamide and (b) class-3 aldehyde dehydrogenase activity, as well as glutathione S-transferase and DT-diaphorase activities, in the estrogen receptor-positive MCF-7/0 cells, it did not do so in two other human breast adenocarcinoma cell lines, MDA-MB-231 and SK-BR-3, each of which is estrogen receptor negative. Expression of the class-3 aldehyde dehydrogenase and the loss of sensitivity to mafosfamide by polycyclic aromatic hydrocarbon-treated MCF-7/0 cells were transient; each returned to essentially basal levels within 15 days when the polycyclic aromatic hydrocarbon was removed from the culture medium. Insensitivity to the oxazaphosphorines on the part of polycyclic aromatic hydrocarbon-treated MCF-7/0 cells was not observed when exposure to mafosfamide (30 min) was in the presence of benzaldehyde or octanal, each a relatively good substrate for cytosolic class-3 aldehyde dehydrogenases, whereas it was retained when exposure to mafosfamide was in the presence of acetaldehyde, a relatively poor substrate for these enzymes. These observations demonstrate that ligands for the Ah receptor can induce a transient, largely oxazaphosphorine-specific, acquired cellular resistance, and they are consistent with the notion that elevated levels of a cytosolic class-3 aldehyde dehydrogenase nearly identical to the prototypical type-1 class-3 aldehyde dehydrogenase expressed by human stomach mucosa account for the Ah receptor ligand-induced oxazaphosphorine-specific acquired resistance, most probably by catalyzing the detoxification of aldophosphamide.
在人乳腺腺癌MCF-7/0细胞中过表达(>100倍)的3类醛脱氢酶,通过在多环芳烃(如甲基胆蒽,3 microM,处理5天)存在下培养,对恶唑磷类药物(如马磷酰胺)产生了抗性(根据LC90判断>30倍)。该酶被分离并进行了表征。其物理和催化特性与原型人胃黏膜胞质3类醛脱氢酶1型ALDH-3相同,只是它虽然催化醛磷酰胺的氧化反应速度不是很快,但胃黏膜酶基本不催化;因此,它被判定为原型酶的一个轻微变体。非Ah受体配体的致癌物、已知可诱导肝细胞色素P450的巴比妥类药物、类固醇激素、一种抗雌激素以及恶唑磷类药物均未诱导该酶或恶唑磷类药物特异性的获得性抗性。虽然甲基胆蒽在雌激素受体阳性的MCF-7/0细胞中诱导了(a)对马磷酰胺的抗性、(b)3类醛脱氢酶活性以及谷胱甘肽S-转移酶和DT-黄递酶活性,但在另外两个人乳腺腺癌细胞系MDA-MB-231和SK-BR-3(均为雌激素受体阴性)中却没有。多环芳烃处理的MCF-7/0细胞中3类醛脱氢酶的表达以及对马磷酰胺敏感性的丧失是短暂的;当从培养基中去除多环芳烃后,15天内各自基本恢复到基础水平。当在苯甲醛或辛醛(两者均为胞质3类醛脱氢酶的相对良好底物)存在下暴露于马磷酰胺(30分钟)时,未观察到多环芳烃处理的MCF-7/0细胞对恶唑磷类药物不敏感的情况,而当在乙醛(这些酶的相对较差底物)存在下暴露于马磷酰胺时,这种不敏感性得以保留。这些观察结果表明,Ah受体配体可诱导一种短暂的、主要是恶唑磷类药物特异性的获得性细胞抗性,并且与以下观点一致:胞质3类醛脱氢酶水平升高,该酶与人类胃黏膜表达的原型1型3类醛脱氢酶几乎相同,最有可能通过催化醛磷酰胺的解毒作用,导致Ah受体配体诱导的恶唑磷类药物特异性获得性抗性产生。